|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1300 AUD | +13.04% |
|
+18.18% | -13.33% |
| 05-29 | Amplia Therapeutics Limited Reports Earnings Results for the Full Year Ended March 31, 2026 | CI |
| 05-28 | Amplia Therapeutics Limited Auditor Raises 'Going Concern' Doubt | CI |
Company Valuation: Amplia Therapeutics Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2023 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 16.49 | 27.16 | 120.6 | 59.03 | - |
| Change | - | - | 343.99% | -51.04% | - |
| Enterprise Value (EV) 1 | 16.49 | 27.16 | 92.72 | 43.53 | 37.53 |
| Change | - | - | 241.42% | -53.05% | -13.78% |
| P/E | -2.64x | -3.27x | -14.3x | -5x | -19.2x |
| PBR | - | - | - | - | - |
| PEG | - | - | 0.6x | -0.1x | 0.3x |
| Capitalization / Revenue | - | - | - | - | 5.9x |
| EV / Revenue | - | - | - | - | 3.75x |
| EV / EBITDA | - | - | -11.2x | -3.79x | -10.7x |
| EV / EBIT | - | - | -11.1x | -3.75x | -10.4x |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -0.0322 | -0.0214 | -0.0164 | -0.023 | -0.006 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 10 |
| EBITDA 1 | - | - | -8.297 | -11.5 | -3.5 |
| EBIT 1 | - | - | -8.389 | -11.6 | -3.6 |
| Net income 1 | -6.242 | -6.572 | -7.707 | -11.6 | -3.6 |
| Net Debt 1 | - | - | -27.85 | -15.5 | -21.5 |
| Reference price 2 | 0.0850 | 0.0700 | 0.2350 | 0.1150 | 0.1150 |
| Nbr of stocks (in thousands) | 194,006 | 387,953 | 513,072 | 513,312 | - |
| Announcement Date | 5/30/23 | 5/30/25 | 5/29/26 | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5x | - | -3.79x | - | 41.39M | |
| 32.76x | 8.52x | 25.76x | 0.06% | 55.19B | |
| 17.19x | 5.15x | 11.19x | 1.75% | 45.75B | |
| -17.99x | 4.24x | -7.4x | -.--% | 22.98B | |
| -36.23x | 11.97x | -34.9x | -.--% | 20.76B | |
| 20.08x | 3.91x | 10.15x | -.--% | 16.26B | |
| 21.67x | 4.34x | 14.36x | -.--% | 15.42B | |
| 16.41x | 4.73x | 11.09x | -.--% | 13.05B | |
| 41.21x | 15.94x | 46.81x | -.--% | 12.45B | |
| -434.11x | 29.51x | -3290.08x | -.--% | 12.37B | |
| Average | -34.40x | 9.81x | -321.68x | 0.2% | 21.43B | |
| Weighted average by Cap. | -11.92x | 8.44x | -179.93x | 0.39% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATX Stock
- Valuation Amplia Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
